Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$82.31 n/a | n/a%
06/28/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 32.64B 24.89B 11.20B 9.70B
Cost of Sales 2.91B 2.74B 2.51B 2.19B
Gross Operating Profit 29.73B 22.15B 8.69B 7.51B
Selling, General, and Administrative Expenses 3.43B 2.98B 1.70B 1.46B
Research & Development 3.01B 2.85B 2.12B 1.76B
Operating Income before D & A (EBITDA) 23.29B 16.32B 4.87B 4.29B
Depreciation & Amortization 1.10B 1.05B 344.70M 278.21M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 154.00M 3.00M -8.89M -37.28M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 22.35B 15.27B 4.52B 3.97B
Interest Expense 688.00M 412.00M 306.89M 360.92M
Pre-Tax Income 21.66B 14.86B 4.21B 3.61B
Income Taxes 3.55B 2.80B 1.15B 1.04B
Minority Interest -2.00M -42.00M -17.52M -17.97M
Net Income From Continuing Operations 18.11B 12.06B 3.06B 2.57B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 18.11B 12.06B 3.06B 2.57B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 18.11B 12.10B 3.07B 2.59B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
18.11B 12.06B 3.06B 2.57B
Preferred Dividends
Net Income Available To Common 18.11B 12.06B 3.06B 2.57B
Basic EPS from Continuing Ops. 12.37 7.95 2.01 1.71
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 12.37 7.95 2.01 1.71
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 12.37 7.95 2.01 1.71
Basic Normalized Net Income/Share 12.37 7.95 2.01 1.71
EPS fr Continuing Ops. 11.91 7.35 1.81 1.64
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 11.91 7.35 1.81 1.64
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 11.91 7.35 1.81 1.64
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
11.91 7.35 1.81 1.64
Dividends Paid per Share 1.29 0.00 0.00 0.00

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter